Английская Википедия:Fluocinolone acetonide

Материал из Онлайн справочника
Версия от 11:55, 8 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Corticosteroid anti-inflammatory drug}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 461101531 | image = Fluocinolone acetonide.svg | alt = | image2 = Fluocinolone acetonide (Ball-n-Stick).png | alt2 = <!--Clinical data--> | tradename = Synalar, Iluvien, others | Drugs.com = {{drugs.com|monograph|fluocinolone-topical}}<br />{{drugs.com|monograph|fluocino...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Fluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching.Шаблон:Citation needed It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. It was first synthesized in 1959 in the Research Department of Syntex Laboratories S.A. Mexico City.[1] Preparations containing it were first marketed under the name Synalar. A typical dosage strength used in dermatology is 0.01–0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin.

Fluocinolone acetonide was also found to strongly potentiate TGF-β-associated chondrogenesis of bone marrow mesenchymal stem/progenitor cells, by increasing the levels of collagen type II by more than 100 fold compared to the widely used dexamethasone.[2]

Fluocinolone acetonide intravitreal implants have been used to treat non-infectious uveitis. A systematic review could not determine with any confidence whether fluocinolone acetonide implants are superior to standard of care treatment for uveitis.[3] A fluocinolone acetonide intravitreal implant with the brand name Iluvien is sold by biopharmaceutical company Alimera Sciences to treat diabetic macular edema (DME).[4]

It was approved for medical use in 1961.[5]

Classification

Fluocinolone is a group V (0.025%) or group VI (0.01%) corticosteroid under US classification.

Society and culture

Brand names

Yutiq.[6]

References

Шаблон:Reflist

Шаблон:Glucocorticoids Шаблон:Vasoprotectives Шаблон:Otologicals Шаблон:Glucocorticoidics Шаблон:Portal bar

Шаблон:Cardiovascular-drug-stub Шаблон:Dermatologic-drug-stub Шаблон:Ophthalmology-stub